Latest AXSM reports update at 2024-05-06: 2024-Q1 ∙ 2023-Q4 ∙ 2023-Q1
  1. Home
  2. Stock quotes
  3. Axsome Therapeutics
  4. Financial Ratios
  5. EV/EBITDA Ratio
Axsome Therapeutics logo
Axsome Therapeutics AXSM
$ 72.51 1.34%
mail-toReport an Error

Axsome Therapeutics EV/EBITDA Ratio 2011-2024 | AXSM

Annual EV/EBITDA Ratio Axsome Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-8.03 -24.3 -41.9 -6.66 -1.47 -2.33 -6.58 - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-1.47 -41.9 -13